PT  - JOURNAL ARTICLE
AU  - Du, Zhanwei
AU  - Wang, Chunyu
AU  - Liu, Caifen
AU  - Bai, Yuan
AU  - Pei, Sen
AU  - Adam, Dillon C.
AU  - Wang, Lin
AU  - Wu, Peng
AU  - Lau, Eric H. Y.
AU  - Cowling, Benjamin J.
TI  - Superspreading of SARS-CoV-2 infections: A Systematic Review and Meta-analysis
AID  - 10.1101/2021.12.09.21267507
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.09.21267507
4099  - http://medrxiv.org/content/early/2021/12/09/2021.12.09.21267507.short
4100  - http://medrxiv.org/content/early/2021/12/09/2021.12.09.21267507.full
AB  - Superspreading in transmission is a feature of SARS-CoV-2 transmission. We conducted a systematic review and meta-analysis on globally reported dispersion parameters of SARS-CoV-2. The pooled estimate was 0.55 (95% CI: 0.30, 0.79). The study location and method were found to be important drivers for its diversity.Competing Interest StatementBJC reports honoraria from AstraZeneca, GSK, Moderna, Pfizer, Roche and Sanofi Pasteur. The authors report no other potential conflicts of interest.Funding StatementWe acknowledge the financial support from the Collaborative Research Fund (Project No. C7123-20G) of the Research Grants Council of the Hong Kong SAR Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable.